Player FM - Internet Radio Done Right
70 subscribers
Checked 2M ago
on iki yıl önce eklendi
İçerik Research To Practice and Dr Neil Love tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Research To Practice and Dr Neil Love veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !
Player FM uygulamasıyla çevrimdışı Player FM !
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
Manage episode 410839336 series 16673
İçerik Research To Practice and Dr Neil Love tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Research To Practice and Dr Neil Love veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.
…
continue reading
165 bölüm
Manage episode 410839336 series 16673
İçerik Research To Practice and Dr Neil Love tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Research To Practice and Dr Neil Love veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.
…
continue reading
165 bölüm
Tüm bölümler
×P
Prostate Cancer Update
1 Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Prostate Cancer 57:10
57:10
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
57:10Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer 30:45
30:45
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
30:45Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer 53:35
53:35
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
53:35Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer.
P
Prostate Cancer Update
1 Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review 1:02:25
1:02:25
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:02:25Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer 1:23:41
1:23:41
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:23:41Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer.
P
Prostate Cancer Update
1 Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer 1:02:31
1:02:31
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:02:31Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition 1:07:29
1:07:29
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:07:29Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium 59:58
59:58
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
59:58Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer.
P
Prostate Cancer Update
1 Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer 1:00:56
1:00:56
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:00:56Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates 32:24
32:24
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
32:24Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.
P
Prostate Cancer Update
1 Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer 1:01:37
1:01:37
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:01:37Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer.
P
Prostate Cancer Update
1 Virtual Case Library: Metastatic Urothelial Bladder Cancer 2:08:14
2:08:14
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
2:08:14Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer.…
P
Prostate Cancer Update
1 Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer 1:01:00
1:01:00
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:01:00Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.
P
Prostate Cancer Update
1 Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting 1:20:37
1:20:37
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
1:20:37Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting.
P
Prostate Cancer Update
1 Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer 2:48:57
2:48:57
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
2:48:57Featuring a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love.
Player FM'e Hoş Geldiniz!
Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.